The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
A study of rovalpituzumab tesirine in frontline treatment of patients with DLL3 expressing extensive small cell lung cancer.
 
Christine L. Hann
Consulting or Advisory Role - Abbvie/Stemcentrx
Research Funding - GlaxoSmithKline; Merrimack
 
Daniel Morgensztern
Consulting or Advisory Role - Abbvie; Bristol-Myers Squibb; Celgene; Heat Biologics
Research Funding - AstraZeneca (Inst); Baxter (Inst); Celgene (Inst); Clovis Oncology (Inst); Heat Biologics (Inst); Incyte (Inst); Merck (Inst); Newlink Genetics (Inst); Stem CentRx (Inst)
 
Afshin Dowlati
Consulting or Advisory Role - ARIAD
Research Funding - AstraZeneca; EMD Serono; Lilly; Loxo; Roche
 
Timothy Francis Burns
No Relationships to Disclose
 
Robert M. Jotte
No Relationships to Disclose
 
Nathan A. Pennell
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Lilly
Research Funding - Astex Pharmaceuticals (Inst); AstraZeneca (Inst); Celgene (Inst); Clovis Oncology (Inst); Genentech (Inst); Merck; Newlink Genetics (Inst); Pfizer (Inst)
 
Stephen Lane Richey
Employment - Texas Oncology
Consulting or Advisory Role - Exelixis; Prometheus; Sanofi
Research Funding - Abbvie; Acerta Pharma; Aptiv Solutions; Bayer Schering Pharma; Biothera; Boehringer Ingelheim; Boston Biomedical; Bristol-Myers Squibb; Celgene; Cerulean Pharma; Daiichi Sankyo; Dendreon; Eisai; Genentech/Roche; Gilead Sciences; GlaxoSmithKline/Novartis; HUYA Bioscience International; ImClone Systems; Immunomedics; Janssen Oncology; Lilly; MedImmune; Merck; Merck; Merrimack; Nektar; Novartis; Oncolytics; Oncothyreon; Pharm-Olam; RTOG; Seagen; US Oncology
 
Juergen Wolf
Consulting or Advisory Role - Amgen; AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Clovis Oncology; Lilly; MSD; Novartis; Pfizer; Roche
Research Funding - Bristol-Myers Squibb; MSD; Novartis; Pfizer; Roche
 
Martin Sebastian
Consulting or Advisory Role - AstraZeneca; Boehringer Ingelheim; Bristol-Myers Squibb; Lilly; MSD; Novartis; Pfizer; Roche
 
Tobias R. Overbeck
No Relationships to Disclose
 
Mark A. Socinski
Honoraria - Genentech
Consulting or Advisory Role - Genentech
Research Funding - Pfizer (Inst)
 
Satwant Lally
Employment - Abbvie/Stemcentrx
Stock and Other Ownership Interests - Abbvie/Stemcentrx
 
Daniel Da Costa
Employment - Abbvie/Stemcentrx
Stock and Other Ownership Interests - Abbvie/Stemcentrx
 
Sreeni Yalamanchili
Employment - Abbvie/Stemcentrx
Stock and Other Ownership Interests - Abbvie/Stemcentrx
 
D. Ross Camidge
No Relationships to Disclose